{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:06:29Z","timestamp":1792044389997,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ebiom.2019.05.025","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T13:17:34Z","timestamp":1558012654000},"page":"126-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML"],"prefix":"10.1016","volume":"44","author":[{"given":"Peter P.","family":"Ruvolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyue W.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian R.","family":"Ruvolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan E.","family":"Hubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Andreeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina A.","family":"Qutub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Kornblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2019.05.025_bb0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbamcr.2015.08.008","article-title":"Galectin 3 as a guardian of the tumor microenvironment","volume":"1863","author":"Ruvolo","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbior.2018.09.003","article-title":"Galectins as regulators of cell survival in the leukemia niche","volume":"71","author":"Ruvolo","year":"2019","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0015","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1073\/pnas.1111138108","article-title":"Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia","volume":"108","author":"Yamamoto-Sugitani","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.leukres.2013.07.026","article-title":"Suppression of SERPINA1-albumin complex formation by galectin-3 overexpression leads to paracrine growth promotion of chronic myelogenous leukemia cells","volume":"38","author":"Nakayama","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0025","first-page":"81","article-title":"Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt\/\u00df-catenin signaling pathway","author":"Hu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0030","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbamcr.2018.04.005","article-title":"Role of MSC-derived galectin 3 in the AML microenvironment","volume":"1865","author":"Ruvolo","year":"2018","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0035","first-page":"5272","article-title":"Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family","volume":"57","author":"Akahani","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10555-013-9450-8","article-title":"Why anti-Bcl-2 clinical trials fail: a solution","volume":"33","author":"Harazono","year":"2014","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/glycob\/cwy001","article-title":"Galectin-3 and cancer stemness","volume":"28","author":"Nangia-Makker","year":"2018","journal-title":"Glycobiology"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0050","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1158\/0008-5472.CAN-04-1816","article-title":"Galectin-3, a novel binding partner of beta-catenin","volume":"64","author":"Shimura","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0055","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1158\/0008-5472.CAN-05-0104","article-title":"Implication of galectin-3 in Wnt signaling","volume":"65","author":"Shimura","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0060","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-08-4153","article-title":"Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity","volume":"69","author":"Song","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0065","doi-asserted-by":"crossref","first-page":"34922","DOI":"10.1074\/jbc.M312697200","article-title":"Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity","volume":"279","author":"Elad-Sfadia","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0070","article-title":"Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbamcr.2015.12.008","article-title":"Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells","volume":"1863","author":"Ruvolo","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0080","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1182\/blood-2009-10-251660","article-title":"GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death","volume":"115","author":"Streetly","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0085","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1158\/2159-8290.CD-17-0539","article-title":"Galectin-3, a Druggable vulnerability for KRAS-addicted cancers","volume":"7","author":"Seguin","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0090","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1182\/blood-2012-07-443762","article-title":"Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia","volume":"121","author":"Cheng","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0095","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bbamcr.2016.03.026","article-title":"The multifaceted roles of the invariant chain CD74--more than just a chaperone","volume":"1863","author":"Schr\u00f6der","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41585-019-0171-9","article-title":"MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential","author":"Penticuff","year":"2019","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","article-title":"Evolving complexity of MIF signaling","volume":"57","author":"Jankauskas","year":"2019","journal-title":"Cell Signal"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0110","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74","volume":"197","author":"Leng","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0120","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cellsig.2005.06.013","article-title":"Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1\/CSN5 and Src kinase activity","volume":"18","author":"Lue","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0125","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1038\/sj.onc.1210318","article-title":"Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5\/JAB1 in the control of autocrine MIF activity","volume":"26","author":"Lue","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0130","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1074\/jbc.M703265200","article-title":"Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex","volume":"283","author":"Gore","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cellsig.2010.08.013","article-title":"Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74","volume":"23","author":"Lue","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0140","doi-asserted-by":"crossref","first-page":"19740","DOI":"10.1074\/jbc.RA118.003935","article-title":"Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-\u03baB signaling","volume":"293","author":"De","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0145","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1182\/blood-2004-03-0890","article-title":"Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies","volume":"104","author":"Stein","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0150","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1158\/1078-0432.CCR-04-0182","article-title":"CD74 is expressed by multiple myeloma and is a promising target for therapy","volume":"10","author":"Burton","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/0008-5472.CAN-16-1095","article-title":"MIF-induced stromal PKC\u03b2\/IL8 is essential in human acute myeloid leukemia","volume":"77","author":"Abdul-Aziz","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0160","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078453","article-title":"Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells","volume":"8","author":"Kornblau","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbacli.2015.07.001","article-title":"Phosphorylation of GSK3\u03b1\/\u03b2 correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients","volume":"4","author":"Ruvolo","year":"2015","journal-title":"BBA Clin"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0175","article-title":"Progeny clustering: a method to identify biological phenotypes","volume":"5","author":"Hu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0180","first-page":"1","article-title":"Shining a light on cell signaling in leukemia through proteomics: relevance for the clinic","volume":"6","author":"Hoff","year":"2018","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-019-0387-2","article-title":"A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia","author":"Hu","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0190","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0195","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0205","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0210","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.febslet.2009.07.058","article-title":"A functional heteromeric MIF receptor formed by CD74 and CXCR4","volume":"583","author":"Schwartz","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0215","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0220","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ccell.2015.05.004","article-title":"Inhibition of the mitochondrial protease ClpP as a therapeutic strategy for human acute myeloid leukemia","volume":"27","author":"Cole","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0225","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1182\/blood-2012-08-447581","article-title":"Prognostic impact and targeting of CRM1 in acute myeloid leukemia","volume":"121","author":"Kojima","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0230","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1182\/blood-2016-01-692244","article-title":"Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia","volume":"128","author":"Piya","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0235","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/febs.13962","article-title":"Mechanistic roles of autophagy in hematopoietic differentiation","volume":"284","author":"Riffelmacher","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0240","doi-asserted-by":"crossref","first-page":"11162","DOI":"10.1074\/jbc.M113.531855","article-title":"Autophagy induced by calcium phosphate precipitates targets damaged endosomes","volume":"289","author":"Chen","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0245","article-title":"Role for PKC \u03b4 in Fenretinide-mediated apoptosis in lymphoid leukemia cells","volume":"2010","author":"Ruvolo","year":"2010","journal-title":"J Signal Transduct"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0250","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1100\/tsw.2010.214","article-title":"Two faces of protein kinase C\u03b4: the contrasting roles of PKC\u03b4 in cell survival and cell death","volume":"10","author":"Basu","year":"2010","journal-title":"Sci World J"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0255","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1002\/j.1460-2075.1995.tb00305.x","article-title":"Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells","volume":"14","author":"Emoto","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054122","article-title":"Protein kinase C regulates human pluripotent stem cell self-renewal","volume":"8","author":"Kinehara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0265","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/leu.2011.146","article-title":"Low expression of PP2A regulatory subunit B55\u03b1 is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patients","volume":"25","author":"Ruvolo","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0270","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ncb2970","article-title":"Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers","volume":"16","author":"Lakshminarayan","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0275","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1434467","article-title":"The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment","volume":"7","author":"Farhad","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0280","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3324\/haematol.2017.172429","article-title":"Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival","volume":"103","author":"Kornblau","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0285","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0290","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","article-title":"Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells","volume":"41","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0295","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1158\/0008-5472.CAN-09-1096","article-title":"Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface","volume":"69","author":"Zhao","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0300","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/glycob\/cwn062","article-title":"Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices","volume":"18","author":"Nobumoto","year":"2008","journal-title":"Glycobiology"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0305","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/bloodadvances.2017013870","article-title":"Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice","volume":"2","author":"Xiao","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0310","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/jcb.21558","article-title":"Control of osteopontin signaling and function by post-translational phosphorylation and protein folding","volume":"102","author":"Kazanecki","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0315","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/13543780903463854","article-title":"Milatuzumab - a promising new immunotherapeutic agent","volume":"19","author":"Berkova","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ebiom.2019.05.025_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203054","article-title":"Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial","volume":"13","author":"Harrison","year":"2018","journal-title":"PLoS One"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419303263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419303263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T22:01:27Z","timestamp":1742335287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419303263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":64,"alternative-id":["S2352396419303263"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.025","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}